Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. af Guerra, N, Michel, F, Gati, A, Gaudin, C, Mishal, Z, Escudier, B, Acuto, O, Chouaib, S, Caignard, A

Classification of current anticancer immunotherapies. af Galluzzi, L, Vacchelli, E, Bravo-San Pedro, J, Buqué, A, Senovilla, L, Baracco, E, Bloy, N, Castoldi, F, Abastado, J, Agostinis, P, Apte, R, Aranda, F, Ayyoub, M, Beckhove, P, Blay, J, Bracci, L, Caignard, A, Castelli, C, Cavallo, F, Celis, E, Cerundolo, V, Clayton, A, Colombo, M, Coussens, L, Dhodapkar, M